Joshua Wilson, MD

Specializes In
  • Pediatric Psychiatry
Languages Spoken
  • English

Appointments

Sees Patients For

MDD, anxiety, autism, ADHD, OCD, PTSD

Hospital Affiliations

  • St. Louis Children's Hospital

Locations

Experience

Board Certifications

  • Child and adolescent psychiatry
  • Adult psychiatry

Academic Title(s)

Instructor of Psychiatry, Child Psychiatry

Research Interests

Adhd, autism, depression, schizophrenia, bipolar, PTSD

Publications & Research

View research profile »

Education

Fellowship: Child Psychiatry

2017 Washington University in St. Louis, MO

Residency: Psychiatry

2015 Washington University in St. Louis, MO

Medical Degree

2012 The University of Texas Health Science Center, Houston, TX

Bachelor of Science: Biology

2008 University of North Texas, Denton, TX

Financial Disclosures
  • St. Charles Psychiatric
    • Additional Disclosures: Outside Employment
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.